|
|---|
Category:Legal-Pre-Filed Exhibits
MONTHYEARML18037A8842018-02-0606 February 2018
Nwmi Commission Hearing Exhibit List - Revision 2
ML18037A8822018-02-0606 February 2018
NWMI-012 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Post-Hearing Questions
ML18037B1162018-02-0606 February 2018
NRC-014 - NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018)
ML18016A9642018-01-23023 January 2018
NWMI-004-R - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation
ML18016A9592018-01-16016 January 2018
NWMI-001-R - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions
ML18016A9622018-01-16016 January 2018
NWMI-003-R - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application
ML18016A9662018-01-16016 January 2018
NWMI-005-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation
ML18016A9692018-01-16016 January 2018
NWMI-006-R - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation
ML18016A9712018-01-16016 January 2018
NWMI-007-R - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation
ML18016A9572018-01-16016 January 2018
Nwmi List of Anticipated Witnesses (Revision 1) - Final
ML18016B0712018-01-16016 January 2018
NRC-002 - Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (Revised Jan. 16, 2018)
ML18016B0722018-01-16016 January 2018
NRC-003 - Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov. 17, 2017) (ADAMS Accession No. ML17313A338) (Revised Jan. 16, 2018)
ML18016B0732018-01-16016 January 2018
NRC-004 - NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554)
ML18016B0742018-01-16016 January 2018
NRC-010 - Staff Presentation Slides - Overview (Jan. 16, 2018)
ML18016B0752018-01-16016 January 2018
NRC-011 - Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018)
ML18016B0762018-01-16016 January 2018
NRC-012 - Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018)
ML18016B0772018-01-16016 January 2018
NRC-013 - Staff Presentation Slides - Environmental Panel (Jan. 16, 2018)
ML18016A9552018-01-16016 January 2018
Nwmi Commission Hearing Exhibit-R List - Final
ML18002A4192018-01-0202 January 2018
NRC Staff Witness List
ML18001A0012018-01-0101 January 2018
Exhibit List (Revised) of Northwest Medical Isotopes, LLC
ML17363A4172017-12-29029 December 2017
Northwest Medical Isotopes, LLC List of Anticipated Witnesses
ML17363A4132017-12-29029 December 2017
NWMI-007 - Northwest Medical Isotopes, LLC Presentation Slides: Environmental Presentation
ML17363A4122017-12-29029 December 2017
NWMI-006 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 2 Presentation
ML17363A4112017-12-29029 December 2017
NWMI-005 - Northwest Medical Isotopes, LLC Presentation Slides: Safety 1 Presentation
ML17363A4102017-12-29029 December 2017
NWMI-004 - Northwest Medical Isotopes, LLC Presentation Slides: Overview Presentation
ML17363A4092017-12-29029 December 2017
NWMI-003 - Statement of Qualifications in Support of Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Construction Permit Application
ML17363A4082017-12-29029 December 2017
NWMI-001 - Northwest Medical Isotopes, LLC Responses to Commission'S Public Pre-Hearing Questions
ML17363A2912017-12-29029 December 2017
Exhibit List of Northwest Medical Isotopes, LLC
ML17363A4162017-12-18018 December 2017
NWMI-010 - Exemption Request Pursuant to 10 CFR 70.17, from Requirement of 10 CFR 70.21(f), Filing, for Northwest Medical Isotopes, LLC Radioisotope Production Facility, Dated December 18, 2017
ML17363A4142017-12-14014 December 2017
NWMI-008 - Federal, State of Missouri, City of Columbia, and Boone County Letters of Support for the Construction and Operation of the Northwest Medical Isotopes, LLC Radioisotope Production Facility
ML18016B0982017-11-30030 November 2017
NRC-008 - Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as Revised Jan. 2018)
ML18016B0702017-11-16016 November 2017
NRC-001 - SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037)
ML18016B1092017-09-30030 September 2017
NRC-006B - Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (Psar), NWMI-2013-021, Rev. 3, Chapters 1 Through 2 (Sep. 2017) (ADAMS Accession Nos. ML17257A022 and ML17257A023)
ML18016B1102017-09-30030 September 2017
NRC-006C - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A024)
ML18016B1142017-09-30030 September 2017
NRC-006D - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025)
ML18016B1152017-09-30030 September 2017
NRC-006E - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 Through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A
ML18016B1172017-09-30030 September 2017
NRC-006F - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 Through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033)
ML18016B1182017-09-30030 September 2017
NRC-006G - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 Through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257
ML17363A4152017-09-15015 September 2017
NWMI-009 - Clean Water Act Section 401 Water Quality Certification of Northwest Medical Isotopes, LLC Facility in Boone County, NUREG-2209/CEK007189
ML18016B0992017-05-31031 May 2017
NRC-009 - NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017) (ADAMS Accession No. ML17130A862)
ML18016B1192015-06-30030 June 2015
NRC-006H - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, Beginning Through 19-130 (Jun. 2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131)
ML18016B1202015-06-30030 June 2015
NRC-006I - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. Oa, Chapter 19, 19-131 Through End (Jun. 2015) (ADAMS Accession Nos. ML15210A128 and ML15210A129)
ML18016B1082015-02-15015 February 2015
NRC-006A - Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in Part))
2018-02-06
[Table view] |
Text
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
)
In the Matter of ) Docket No. 50-609-CP
)
NORTHWEST MEDICAL ISOTOPES, LLC )
)
(Medical Radioisotope Production Facility) ) January 1, 2018
)
EXHIBIT LIST NORTHWEST MEDICAL ISOTOPES, LLC EVIDENTIARY HEARING In accordance with the Commissions notice dated November 21, 2017, Northwest Medical Isotopes, LLC (NWMI) hereby submits its list of exhibits for the evidentiary hearing for Docket No.
50-609-CP to be held on January 23, 2018.
Below is a crosswalk identifying the NWMI Exhibit number with the corresponding Sponsoring Witness(es) and Document Title.
Exhibit Panel Number/ Sponsoring Number Witness(es) Document Description/Title NWMI-001 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Public Pre-Hearing Questions NWMI-002 Carolyn C. Haass Northwest Medical Isotopes, LLC Responses to Commissions Non- Public Pre-Hearing Questions NWMI-003 Statement of Qualifications: Statement of Qualifications in Support of Roy W. Brown, Ralph A. Butler, Northwest Medical Isotopes, LLC Medical Michael R. Corum, Gary L. Dunford, Radioisotope Production Facility Construction Nicholas F. Fowler, Carolyn C. Haass, Permit Application Stephen R. Reese Exhibit List (Docket No. 50-609-CP) 1
Exhibit Panel Number/ Sponsoring Number Witness(es) Document Description/Title NWMI-004 Overview Panel: Roy W. Brown, Northwest Medical Isotopes, LLC Presentation Nicholas F. Fowler, Carolyn C. Haass, Slides: Overview Presentation Stephen R. Reese NWMI-005 Safety Panel 1: Ralph A. Butler, Northwest Medical Isotopes, LLC Presentation Michael R. Corum, Gary L. Dunford, Slides: Safety 1 Presentation Carolyn C. Haass, Stephen R. Reese NWMI-006 Safety Panel 2: Michael R. Corum, Northwest Medical Isotopes, LLC Presentation Gary L. Dunford, Carolyn C. Haass, Slides: Safety 2 Presentation Stephen R. Reese NWMI-007 Environmental Panel: Michael R. Northwest Medical Isotopes, LLC Presentation Corum, Gary L. Dunford, Carolyn C. Slides: Environmental Presentation Haass, Stephen R. Reese NWMI-008 Letters of Support: U.S. Senators Federal, State of Missouri, City of Columbia, Ron Wyden and Claire McCaskill; and Boone County letters of support for the Boone County Commissioner construction and operation of the Northwest Dan Atwill; Manager, City of Columbia, Medical Isotopes, LLC Radioisotope Missouri, Mike Mathis; Missouri Production Facility Department of Economic Development, Terrance M. Maglich, Project Manager NWMI-009 Missouri Department of Natural Clean Water Act Section 401 Water Quality Resources Letter to Northwest Medical Certification of Northwest Medical Isotopes, Isotopes, LLC, dated September 15, LLC Facility in Boone County, NUREG-2017 2209/CEK007189 NWMI-010 Northwest Medical Isotopes, LLC Letter Exemption Request Pursuant to 10 CFR 70.17, (NWMI-LTR-2017-016) to U.S. Nuclear from Requirement of 10 CFR 70.21(f),
Regulatory Commission, dated Filing, for Northwest Medical Isotopes, December 18, 2017 LLC Radioisotope Production Facility, dated December 18, 2017 NWMI-011 Carolyn C. Haass Applicants Pre-Filed Testimony of Carolyn C. Haass for the Mandatory Hearing on Uncontested Issues for the Northwest Medical Isotopes, LLC Medical Radioisotope Production Facility Exhibit List (Docket No. 50-609-CP) 2
Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Carolyn Digitally signed by Carolyn C Haass C Haass Date: 2018.01.01 11:18:01 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 1st day of January 2018 Exhibit List (Docket No. 50-609-CP) 3
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION
)
In the Matter of ) Docket No. 50-609-CP
)
NORTHWEST MEDICAL ISOTOPES, LLC )
)
(Medical Radioisotope Production Facility) ) January 1, 2018
)
CERTIFICATE OF SERVICE I hereby certify that on this date, a copy of the Exhibit List of Northwest Medical Isotopes, LLC for the Hearing on Uncontested Issues and Exhibit NWMI-011 were submitted through the NRC E-filing system.
Respectfully submitted, Executed in Accord with 10 C.F.R. § 2.304(d)
Carolyn C Digitally signed by Carolyn C Haass Haass Date: 2018.01.01 11:17:43 -07'00' Signed (electronically) by Carolyn C. Haass Carolyn C. Haass Northwest Medical Isotopes, LLC - Chief Operating Officer 815 NW 9th Ave, Suite 256 Corvallis, OR 97330 Phone: 509-430-6921 Email: carolyn.haass@nwmedicalisotopes.com Dated in Denver, Colorado this 1st day of January 2018 Certificate of Service (Docket No. 50-609-CP)